T cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer -induced weakness in the patient’s immune system – a weakness that in principle could be…

Be the first to comment

Leave a Reply

Your email address will not be published.